test-placeholder-02.png
Medication Detail
Reslizumab | New Drug Approvals
CINQAIR® (reslizumab) Injection – About Asthma Control
Teva Support Solutions ® provides comprehensive access and affordability support for you and your patients
Cinqair: Package Insert - Drugs.com
Subcutaneous Cinqair results add to Teva's troubles
Teva gets EU nod for severe asthma drug Cinqaero - PMLiVE
CINQAIR - Teva Pharmaceutical Industries Limited Trademark Registration
How patients use CINQAIR® (reslizumab) Injection Cost Support Program Card
Dosing and Administration
Attachment: Product Information: Reslizumab
Drug Analysis: Cinqair - Research and Markets
Product Monograph Template - Schedule D]
761033Orig1s000
Flopped trials dash Teva's hopes of battling GSK, AZ with subcutaneous Cinqair | Fierce Pharma
Cinqair Reslizumab Injection
Cinqair Prices, Coupons & Savings Tips - GoodRx
Help eligible, commercially insured patients save on out-of-pocket costs for CINQAIR*
CINQAIR® (reslizumab) Injection - Savings and Support
Chest Medicine Made Easy-Dr Deepu: FDA approves Injectable drug for uncontrolled Asthma
CINQAIR® (reslizumab) Injection – About Asthma Control
New Drug Product: Cinqair - MPR
Administering CINQAIR.
